Jan 25, 2015 at 16:54 | Source: PTI
Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined entity would be to rebuild the confidence of health regulators.
Jan 24, 2015 at 14:45 | Source: PTI
German drug regulator has welcomed the European Medicine Agency's (EMA) decision to suspend the marketing authorisation of around 700 generic drugs subjected to clinical trials by India's GVK Biosciences.
Jan 23, 2015 at 15:12 | Source: Moneycontrol.com
Investors offloaded a huge chunk of shares of Ipca Laboratories on Friday. The stock fell nearly 9 percent intraday. The pharmaceutical firm received import alert from US Food and Drug Administration for its Ratlam unit due to violations of standard production practices.
Jan 23, 2015 at 11:14 | Source: Moneycontrol.com
Beryl Drugs has entered into an agreement with the Managing Director, Madhya Pradesh Public Health Services, Procurement Corporation Ltd. (MPPHSCL), Bhopal (M.P.) for supply of the medicines manufactured by the Company to the tune of Rs 11.80 crore, which will boost up the Company's turnover by 60% to 65%.
Jan 22, 2015 at 13:34 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 07, 2015, to consider, approve and take on record the unaudited financial results for the quarter ended December 31, 2014.
Jan 21, 2015 at 08:33 | Source: CNBC-TV18
US supreme court has suggested that Appeals court did not use the right approach in analyzing whether Teva's September 2015 patent is valid or not.
Jan 20, 2015 at 14:06 | Source: Moneycontrol.com
Beryl Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 20, 2015, has considered and approved the appointment of Mrs. Neha Sharma as Compliance Officer of the Company.
Jan 20, 2015 at 12:27 | Source: PTI
The company said it has been granted one product patent from Australia, two product patents from Japan and one product patent from Hong Kong corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases.
Jan 20, 2015 at 12:00 | Source: Moneycontrol.com
Under the pact, Gilead has extended non-exclusive rights to Strides to manufacture and distribute Under the pact, Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide, both as a single agent product and in combination with other drugs.
Jan 19, 2015 at 22:24 | Source: CNBC-TV18
A new clinical trial policy may be just what the doctor ordered for India, which has been losing out as the destination of choice for drug makers globally. CNBC-TV18's Archana Shukla reports that with the policy, which enables quicker approvals and better compensation for participants, India may soon regain its glory days in this area.